The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that incidence rate is the most appropriate epidemiologic measure to assess whether there is an increase in transmission of healthcare-associated infections, including methicillin-resistant Staphylococcus aureus (MRSA). Incidence measures the number of new cases occurring in a defined population over a specific period of time, making it the key indicator for evaluating changes in infection risk and ongoing transmission.
When an infection preventionist suspects an increase in healthcare-associated MRSA infections, the primary concern is whether new cases are occurring more frequently than expected. Incidence rate allows comparison over time (e.g., month-to-month or quarter-to-quarter) and can be standardized using appropriate denominators such as patient days or device days. This enables detection of trends, clusters, or outbreaks and supports timely intervention.
Prevalence rate (Option C) reflects the total number of existing cases at a given point in time, including both old and new infections. While useful for understanding disease burden, prevalence cannot distinguish between ongoing transmission and prolonged duration of existing cases. Mortality rate (Option A) and case fatality rate (Option D) measure outcomes of infection severity, not transmission or acquisition.
For the CIC® exam, it is critical to recognize that incidence rate is the correct measure for assessing increases in healthcare-associated infection transmission, making it the best choice for this scenario.
